https://www.yiliao.com/index.php?action=history&feed=atom&title=ATXN1L
ATXN1L - 版本历史
2026-04-19T05:47:04Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=ATXN1L&diff=315383&oldid=prev
2026年1月22日 (四) 09:36 77921020
2026-01-22T09:36:09Z
<p></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="zh-Hans-CN">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">2026年1月22日 (四) 09:36的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l178" >第178行：</td>
<td colspan="2" class="diff-lineno">第178行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div></div></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div></div></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">```</del></div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div></div></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div></div></div></td></tr>
</table>
77921020
https://www.yiliao.com/index.php?title=ATXN1L&diff=315382&oldid=prev
2026年1月22日 (四) 09:31 77921020
2026-01-22T09:31:08Z
<p></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="zh-Hans-CN">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">2026年1月22日 (四) 09:31的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >第1行：</td>
<td colspan="2" class="diff-lineno">第1行：</td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> </div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">```</del></div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"></div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <strong>ATXN1L</strong>（Ataxin-1-like），曾被称为 <strong>Boat</strong>，是脊髓小脑共济失调 1 型（SCA1）致病蛋白 <strong>[[ATXN1]]</strong> 的功能性旁系同源物（Paralog）。作为一种转录核心抑制因子，ATXN1L 与 <strong>[[CIC]]</strong> (Capicua) 蛋白形成稳定的异源复合物，共同调控中枢神经系统的发育和稳态。在神经退行性疾病研究中，ATXN1L 具有独特的临床转化价值：研究表明，提高 ATXN1L 的水平可以通过“分子竞争”机制，置换出结合在 CIC 上的毒性突变型 ATXN1，从而显著缓解 <strong>[[SCA1]]</strong> 的神经毒性。此外，ATXN1L 的缺失或突变与<strong>[[智力障碍]]</strong>和自闭症谱系特征密切相关。</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <strong>ATXN1L</strong>（Ataxin-1-like），曾被称为 <strong>Boat</strong>，是脊髓小脑共济失调 1 型（SCA1）致病蛋白 <strong>[[ATXN1]]</strong> 的功能性旁系同源物（Paralog）。作为一种转录核心抑制因子，ATXN1L 与 <strong>[[CIC]]</strong> (Capicua) 蛋白形成稳定的异源复合物，共同调控中枢神经系统的发育和稳态。在神经退行性疾病研究中，ATXN1L 具有独特的临床转化价值：研究表明，提高 ATXN1L 的水平可以通过“分子竞争”机制，置换出结合在 CIC 上的毒性突变型 ATXN1，从而显著缓解 <strong>[[SCA1]]</strong> 的神经毒性。此外，ATXN1L 的缺失或突变与<strong>[[智力障碍]]</strong>和自闭症谱系特征密切相关。</div></td></tr>
<tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l18" >第18行：</td>
<td colspan="2" class="diff-lineno">第15行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <div style="padding: 25px; text-align: center; background-color: #f8fafc;"></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <div style="padding: 25px; text-align: center; background-color: #f8fafc;"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <div style="display: inline-block; background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 20px; box-shadow: 0 4px 10px rgba(0,0,0,0.04);"></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <div style="display: inline-block; background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 20px; box-shadow: 0 4px 10px rgba(0,0,0,0.04);"></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> [[Image:ATXN1L_AXH_domain_structure.png|100px|ATXN1L AXH 结构域]]</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> [[Image:ATXN1L_AXH_domain_structure.png|100px|ATXN1L AXH 结构域<ins class="diffchange diffchange-inline">|链接=Special:FilePath/ATXN1L_AXH_domain_structure.png</ins>]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </div></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </div></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">SCA1 毒性抑制 / 发育调控</div></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">SCA1 毒性抑制 / 发育调控</div></div></td></tr>
<tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l84" >第84行：</td>
<td colspan="2" class="diff-lineno">第81行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <br>ATXN1L 与 ATXN1 竞争性地结合 CIC。由于 ATXN1L 缺乏多聚谷氨酰胺 (PolyQ) 扩增区域，它形成复合物更为稳定且无毒。当 ATXN1L 水平升高时，它可以将突变的、具有细胞毒性的 ATXN1 从 CIC 复合物中“挤”出来，使其被细胞降解或形成无毒的聚集体，从而恢复复合物的正常功能。</li></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <br>ATXN1L 与 ATXN1 竞争性地结合 CIC。由于 ATXN1L 缺乏多聚谷氨酰胺 (PolyQ) 扩增区域，它形成复合物更为稳定且无毒。当 ATXN1L 水平升高时，它可以将突变的、具有细胞毒性的 ATXN1 从 CIC 复合物中“挤”出来，使其被细胞降解或形成无毒的聚集体，从而恢复复合物的正常功能。</li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div></ul></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div></ul></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[Image:CIC_ATXN1L_complex_repression_model.png|100px|CIC-ATXN1L 复合物介导的转录抑制与竞争机制]]</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[Image:CIC_ATXN1L_complex_repression_model.png|100px|CIC-ATXN1L 复合物介导的转录抑制与竞争机制<ins class="diffchange diffchange-inline">|链接=Special:FilePath/CIC_ATXN1L_complex_repression_model.png</ins>]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><h2 style="background: #fff1f2; color: #9f1239; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #9f1239; font-weight: bold;">临床警示：治疗 SCA1 的双刃剑</h2></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><h2 style="background: #fff1f2; color: #9f1239; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #9f1239; font-weight: bold;">临床警示：治疗 SCA1 的双刃剑</h2></div></td></tr>
<tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l139" >第139行：</td>
<td colspan="2" class="diff-lineno">第136行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline"> </del></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline"> </ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> [1] <strong>Bowman AB, Lam YC, Jafar-Nejad P, et al. (2007).</strong> <em>Duplication of Atxn1l suppresses Sca1 neuropathology by decreasing incorporation of mutant Atxn1 into native complexes.</em> <strong>[[Nature Genetics]]</strong>. 2007;39(3):373-379.<br></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> [1] <strong>Bowman AB, Lam YC, Jafar-Nejad P, et al. (2007).</strong> <em>Duplication of Atxn1l suppresses Sca1 neuropathology by decreasing incorporation of mutant Atxn1 into native complexes.</em> <strong>[[Nature Genetics]]</strong>. 2007;39(3):373-379.<br></div></td></tr>
</table>
77921020
https://www.yiliao.com/index.php?title=ATXN1L&diff=315381&oldid=prev
77921020：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2026-01-22T09:30:50Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
```<br />
<div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>ATXN1L</strong>（Ataxin-1-like），曾被称为 <strong>Boat</strong>，是脊髓小脑共济失调 1 型（SCA1）致病蛋白 <strong>[[ATXN1]]</strong> 的功能性旁系同源物（Paralog）。作为一种转录核心抑制因子，ATXN1L 与 <strong>[[CIC]]</strong> (Capicua) 蛋白形成稳定的异源复合物，共同调控中枢神经系统的发育和稳态。在神经退行性疾病研究中，ATXN1L 具有独特的临床转化价值：研究表明，提高 ATXN1L 的水平可以通过“分子竞争”机制，置换出结合在 CIC 上的毒性突变型 ATXN1，从而显著缓解 <strong>[[SCA1]]</strong> 的神经毒性。此外，ATXN1L 的缺失或突变与<strong>[[智力障碍]]</strong>和自闭症谱系特征密切相关。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox mw-collapsible mw-collapsed" style="width: 100%; max-width: 320px; margin: 0 auto 35px auto; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%); text-align: center; cursor: pointer;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">ATXN1L</div><br />
<div style="font-size: 0.7em; opacity: 0.85; margin-top: 4px; white-space: nowrap;">SCA1 Suppressor & Transcriptional Repressor (点击展开)</div><br />
</div><br />
<br />
<div class="mw-collapsible-content"><br />
<div style="padding: 25px; text-align: center; background-color: #f8fafc;"><br />
<div style="display: inline-block; background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 20px; box-shadow: 0 4px 10px rgba(0,0,0,0.04);"><br />
[[Image:ATXN1L_AXH_domain_structure.png|100px|ATXN1L AXH 结构域]]<br />
</div><br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">SCA1 毒性抑制 / 发育调控</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0; width: 40%;">基因符号</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">ATXN1L</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">别名</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">BOAT, HAHO</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">染色体位置</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">16q22.2</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">Entrez Gene</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">3423</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">UniProt ID</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">P0C7V6</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">OMIM 编号</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">609673</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">功能角色</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;">转录共抑制, 神经保护</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">氨基酸数</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #b91c1c;"><strong>689 aa</strong></td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">分子量</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">74.6 kDa</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">关键结构域</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;"><strong>[[AXH Domain]]</strong></td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569;">临床意义</th><br />
<td style="padding: 6px 12px; color: #b91c1c;">SCA1 治疗靶点, 智力障碍</td><br />
</tr><br />
</table><br />
</div><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">分子机制：沉默者的替身</h2><br />
<br />
<p style="margin: 15px 0; text-align: justify;"><br />
ATXN1L 和 ATXN1 拥有高度保守的 <strong>[[AXH结构域]]</strong>，这使得它们在功能上存在冗余，但也存在微妙的竞争关系。<br />
</p><br />
<br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>CIC-ATXN1L 复合物：</strong><br />
<br>ATXN1L 主要与 HMG 盒转录抑制因子 <strong>[[CIC]]</strong> (Capicua) 结合。在正常大脑中，CIC-ATXN1L 复合物占据在特定靶基因（如 ETV1/4/5）的启动子上，抑制其表达。这一过程对于维持神经元的正常发育和突触可塑性至关重要。</li><br />
<li style="margin-bottom: 12px;"><strong>分子置换 (Molecular Displacement)：</strong><br />
<br>ATXN1L 与 ATXN1 竞争性地结合 CIC。由于 ATXN1L 缺乏多聚谷氨酰胺 (PolyQ) 扩增区域，它形成复合物更为稳定且无毒。当 ATXN1L 水平升高时，它可以将突变的、具有细胞毒性的 ATXN1 从 CIC 复合物中“挤”出来，使其被细胞降解或形成无毒的聚集体，从而恢复复合物的正常功能。</li><br />
</ul><br />
[[Image:CIC_ATXN1L_complex_repression_model.png|100px|CIC-ATXN1L 复合物介导的转录抑制与竞争机制]]<br />
<br />
<h2 style="background: #fff1f2; color: #9f1239; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #9f1239; font-weight: bold;">临床警示：治疗 SCA1 的双刃剑</h2><br />
<div style="background-color: #fff5f5; border-left: 5px solid #e11d48; padding: 15px 20px; margin: 20px 0; border-radius: 4px;"><br />
<h3 style="margin-top: 0; color: #be123c; font-size: 1.1em;">保护与缺失的后果</h3><br />
<p style="margin-bottom: 0; text-align: justify; font-size: 0.95em; color: #334155;"><br />
ATXN1L 的临床重要性主要体现在其作为 SCA1 潜在疗法的角色，以及其自身功能缺失导致的遗传病。<br />
</p><br />
<p style="margin-top: 10px; margin-bottom: 0; text-align: justify; font-size: 0.95em; color: #334155;"><br />
<strong>治疗 SCA1 的潜力：</strong><br><br />
在 SCA1 小鼠模型中，人为过表达 ATXN1L 能够显著抑制神经退行性病变。这证明了通过基因治疗或小分子药物上调内源性 ATXN1L 是治疗 SCA1 的一条极具前景的策略。<br />
<br><br><br />
<strong>ATXN1L 缺乏综合征：</strong><br><br />
虽然增加 ATXN1L 有益，但其<strong>缺失</strong>是致病的。由于 16q22.2 微缺失或点突变导致的 ATXN1L 功能丧失，与<strong>智力障碍</strong>、语言发育迟缓、自闭症行为以及先天性心脏缺陷有关。这表明 ATXN1L 并非可有可无，而是胚胎发育的关键调节因子。<br />
</p><br />
</div><br />
<br />
<div style="overflow-x: auto; margin: 30px auto; max-width: 90%;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.95em; text-align: left;"><br />
<tr style="background-color: #f8fafc; border-bottom: 2px solid #0f172a;"><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #0f172a; width: 25%;">疾病/状态</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #475569;">ATXN1L 改变</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #1e40af;">临床效应 / 机制</th><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">[[SCA1]] (脊髓小脑共济失调1型)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">人为过表达 (Therapeutic)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">置换突变 ATXN1，恢复 CIC 复合物功能，显著减轻小脑浦肯野细胞的变性。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">[[智力障碍]] / [[ASD]]</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">功能缺失突变 (LOF)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">导致下游靶基因去抑制（过度表达），扰乱神经发育程序，引起认知障碍和行为异常。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">[[肺癌]] / [[胃癌]]</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">表达失调</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">由于 CIC-ATXN1L 复合物是 MAPK 通路的负调控因子，ATXN1L 的丢失可能促进肿瘤转移。</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">研究与治疗前景</h2><br />
<p style="margin: 15px 0; text-align: justify;"><br />
针对 ATXN1L 的研究主要集中在如何安全地利用其“保护性”特征。<br />
</p><br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>SCA1 基因疗法：</strong><br />
<br>利用 AAV 载体递送 ATXN1L cDNA 到小脑，已在动物模型中验证了有效性。关键在于控制表达水平，避免过量导致的副作用。</li><br />
<li style="margin-bottom: 12px;"><strong>蛋白-蛋白相互作用 (PPI) 调节：</strong><br />
<br>寻找能够增强 ATXN1L 与 CIC 结合亲和力，或者破坏突变 ATXN1 与 CIC 结合的小分子药物。</li><br />
</ul><br />
<br />
<div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"><br />
<span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>Bowman AB, Lam YC, Jafar-Nejad P, et al. (2007).</strong> <em>Duplication of Atxn1l suppresses Sca1 neuropathology by decreasing incorporation of mutant Atxn1 into native complexes.</em> <strong>[[Nature Genetics]]</strong>. 2007;39(3):373-379.<br><br />
<span style="color: #475569;">[学术点评]：里程碑发现。Zoghbi 实验室首次发现 ATXN1L (Boat) 的过表达可以挽救 SCA1 小鼠的表型，提出了基于旁系同源物竞争的治疗新策略。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>Lee Y, Fryer JD, Kang H, et al. (2011).</strong> <em>ATXN1 protein family and CIC form a functional complex involved in CNS development.</em> <strong>[[Nature Neuroscience]]</strong>. 2011;14(6):786-793.<br><br />
<span style="color: #475569;">[学术点评]：机制解析。明确了 ATXN1/ATXN1L 与 CIC 形成转录抑制复合物的生化基础，以及该复合物在中枢神经系统发育中的关键作用。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[3] <strong>Rousseau J, et al. (2022).</strong> <em>Loss of function variants in ATXN1L are associated with developmental disorders and intellectual disability.</em> <strong>[[American Journal of Human Genetics]]</strong>. 2022;109(10):1858-1870.<br><br />
<span style="color: #475569;">[学术点评]：临床遗传学。确定了 ATXN1L 是人类智力障碍和发育迟缓的新致病基因，填补了其在单基因遗传病中的认知空白。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-family: 'Helvetica Neue', Arial, sans-serif; font-size: 0.9em;"><br />
<div style="background-color: #eff6ff; color: #1e40af; padding: 8px 15px; font-weight: bold; text-align: center; border-bottom: 1px solid #dbeafe;"><br />
ATXN1L · 知识图谱<br />
</div><br />
<table style="width: 100%; border-collapse: collapse; background-color: #ffffff;"><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">孪生兄弟</td><br />
<td style="padding: 10px 15px; color: #334155;">[[ATXN1]] (SCA1致病蛋白) • [[AXH结构域]] • [[PolyQ]] (无)</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">核心伙伴</td><br />
<td style="padding: 10px 15px; color: #334155;">[[CIC]] (Capicua) • [[U2AF65]] (RNA加工) • [[14-3-3]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">相关通路</td><br />
<td style="padding: 10px 15px; color: #334155;">[[RTK-Ras-MAPK]] • [[小脑发育]] • [[转录抑制]]</td><br />
</tr><br />
<tr><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">临床关联</td><br />
<td style="padding: 10px 15px; color: #334155;">[[SCA1]] (保护因子) • [[智力障碍]] (致病因子) • [[自闭症]]</td><br />
</tr><br />
</table><br />
</div><br />
<br />
```<br />
<br />
</div></div>
77921020